TUMOUR MARKER INCREASED

This adverse event was reported 4803 times

These drugs are most commonly taken by patients reporting TUMOUR MARKER INCREASED:

# Drug Count
0 PALBOCICLIB 876
1 FULVESTRANT 675
2 LETROZOLE 569
3 LETROZOLE TABLETS 420
4 NIRAPARIB 359
5 CAPECITABINE 351
6 RIBOCICLIB 350
7 EVEROLIMUS 267
8 EXEMESTANE 262
9 DENOSUMAB 257
See all common drugs associated with TUMOUR MARKER INCREASED

TUMOUR MARKER INCREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ELACESTRANT 230 0.0320
1 FULVESTRANT 675 0.0201
2 NIRAPARIB 359 0.0162
3 EXEMESTANE 262 0.0122
4 RIBOCICLIB 350 0.0107
5 PALBOCICLIB 876 0.0092
6 LETROZOLE 569 0.0091
7 OLAPARIB 185 0.0086
8 LETROZOLE TABLETS 420 0.0086
9 ANASTROZOLE TABLETS 161 0.0073
See all drugs enriched for association with TUMOUR MARKER INCREASED